Medherant touts results for ibuprofen transdermal patch

Medherant said today that it successfully finished two Phase I studies with its ibuprofen transdermal drug-delivery patch. According to the UK-based company, the Tepi patch was well tolerated by the participants of a skin irritation study. Get the full story at our sister site, Drug Delivery Business News. The post Medherant touts results for ibuprofen transdermal patch appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Clinical Trials Drug-Device Combinations Pharmaceuticals medherant Source Type: news